This is a preview of subscription content, log in via an institution to check access.
Notes
including pustular psoriasis
indicated for the treatment of active rheumatoid arthritis and active psoriatic arthritis.
including the Summary of Product Characteristics and Package Leaflet.
Reference
Health Products Regulatory Authority. Aubagio (teriflunomide) - Risk of new onset of psoriasis and worsening of pre-existing psoriasis. Internet Document : [1 page], 13 May 2020. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/
Rights and permissions
About this article
Cite this article
Teriflunomide linked with new onset and worsening of psoriasis. Reactions Weekly 1805, 1 (2020). https://doi.org/10.1007/s40278-020-78711-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-78711-z